SCHEMBL6598447

SCHEMBL6598447

O=C(Nc1cccc(Br)c1)OCc1cn(-c2cc3cc(C(=O)O)c(=O)[nH]c3cc2[N+](=O)[O-])cn1

nearest known ligand 0.77

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 1/20 0.61
GRIA2 P42262 1/20 0.61
GRIA3 P42263 1/20 0.61
GRIA4 P48058 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597747 0.93 GRIA1 (0.68) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6597226 0.92 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6598472 0.92 GRIA1 (0.67) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6596045 0.88 GRIA1 (0.59) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6598434 0.88 GRIA1 (0.77) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6596915 0.88 GRIA1 (0.58) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6595849 0.87 GRIA1 (0.67) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6598289 0.87 GRIA1 (0.67) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6599242 0.86 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6599679 0.85 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156044-B1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-08-25 EP disclosed
US-6562839-B1 Effective for the therapy of disorder of cerebral nerve cells as antagonists against excitatory amino acid receptors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-05-13 US disclosed
EP-1156044-A1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2001-11-21 EP disclosed